Skip to main content
Top

06-04-2024 | Peritoneal Dialysis | Case Report

Peritoneal dialysis-associated infection caused by Mycobacterium abscessus in a pediatric patient on continuous peritoneal dialysis without switching to hemodialysis

Authors: Koji Takata, Takashi Omae, Yuri Hamano, Tomoaki Ishikawa, Keiji Nogami

Published in: CEN Case Reports

Login to get access

Abstract

Most peritoneal dialysis (PD)-associated infections caused by Mycobacterium abscessus (M. abscessus) require a transfer from PD to hemodialysis (HD). Here, we report a pediatric case of exit-site and tunnel infections caused by M. abscessus, for whom PD was continued with catheter replacement, debridement of the infected site, and the administration of multiple antibacterial agents. A 10-year-old boy with end-stage kidney disease secondary to juvenile nephronophthisis with NPHP1 deletion, for whom PD was initiated at the age of 9 years, was admitted to the hospital with complaints of fever, pus at the exit-site of the PD catheter, and poor PD drainage. The dialysis effluent culture results were negative; however, M. abscessus was detected in the pus at the exit-site of the PD catheter. The management of HD was expected to be challenging owing to the presence of developmental disorders. Therefore, PD was continued with the simultaneous removal of the PD catheter, reinsertion of a new catheter at a new site, and debridement of the infected site. Multiple antibacterial therapies were administered for 2 months, and the patient was eventually discharged without switching to HD. To the best of our knowledge, this is the first pediatric case of a PD-associated infection caused by M. abscessus, for whom PD was continued without switching to HD. This treatment strategy is not generally recommended but may be an option for patients without peritonitis who have difficulty switching to HD.
Literature
1.
go back to reference Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42:110–53.CrossRefPubMed Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42:110–53.CrossRefPubMed
2.
3.
go back to reference Yoshimura R, Kawanishi M, Fujii S, Yamauchi A, Takase K, Yoshikane K, et al. Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report. BMC Nephrol. 2018;19:341.CrossRefPubMedPubMedCentral Yoshimura R, Kawanishi M, Fujii S, Yamauchi A, Takase K, Yoshikane K, et al. Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report. BMC Nephrol. 2018;19:341.CrossRefPubMedPubMedCentral
4.
go back to reference Chamarthi G, Modi D, Andreoni K, Shukla AM. Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection? CEN Case Rep. 2021;10:483–9.CrossRefPubMedPubMedCentral Chamarthi G, Modi D, Andreoni K, Shukla AM. Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection? CEN Case Rep. 2021;10:483–9.CrossRefPubMedPubMedCentral
5.
go back to reference Ellis EN, Schutze GE, Wheeler JG. Nontuberculous mycobacterial exit-site infection and abscess in a peritoneal dialysis patient. Pediatr Nephrol. 2005;20:1016–8.CrossRefPubMed Ellis EN, Schutze GE, Wheeler JG. Nontuberculous mycobacterial exit-site infection and abscess in a peritoneal dialysis patient. Pediatr Nephrol. 2005;20:1016–8.CrossRefPubMed
6.
go back to reference Pinapala A, Koh LJ, Ng KH, Tambyah PA, Yap HK. Clofazimine in Mycobacterium abscessus peritonitis: a pediatric case report. Perit Dial Int. 2021;41:104–9.CrossRefPubMed Pinapala A, Koh LJ, Ng KH, Tambyah PA, Yap HK. Clofazimine in Mycobacterium abscessus peritonitis: a pediatric case report. Perit Dial Int. 2021;41:104–9.CrossRefPubMed
7.
go back to reference Imam O, AI-Zubaidi K, Janahi M, Imam A, Leghrouz B, Dobson S, et al. Peritoneal dialysis-associated peritonitis caused by Mycobacterium abscessus in children-a case report. Open Forum Infect Dis. 2021;8:579.CrossRef Imam O, AI-Zubaidi K, Janahi M, Imam A, Leghrouz B, Dobson S, et al. Peritoneal dialysis-associated peritonitis caused by Mycobacterium abscessus in children-a case report. Open Forum Infect Dis. 2021;8:579.CrossRef
8.
go back to reference Nakano S, Miyazaki N, Michigami T, Yazawa K, Yanagihara I, Yamamoto K. A case of preschool child with a successful kidney transplant following the long-term administration of antibiotics to treat peritoneal dialysis-related ESI/peritonitis by Mycobacterium abscessus. CEN Case Rep. 2022;11:408–11.CrossRefPubMedPubMedCentral Nakano S, Miyazaki N, Michigami T, Yazawa K, Yanagihara I, Yamamoto K. A case of preschool child with a successful kidney transplant following the long-term administration of antibiotics to treat peritoneal dialysis-related ESI/peritonitis by Mycobacterium abscessus. CEN Case Rep. 2022;11:408–11.CrossRefPubMedPubMedCentral
9.
go back to reference Kameyama H, Mori Y, Kimura T, Sugishita C, Adachi T, Sonomura K, et al. A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient. Ther Apher Dial. 2007;11:449–51.CrossRefPubMed Kameyama H, Mori Y, Kimura T, Sugishita C, Adachi T, Sonomura K, et al. A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient. Ther Apher Dial. 2007;11:449–51.CrossRefPubMed
10.
go back to reference Lo MW, Mak SK, Wong YY, Lo KC, Chan SF, Tong GM, et al. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int. 2013;33:267–72.CrossRefPubMedPubMedCentral Lo MW, Mak SK, Wong YY, Lo KC, Chan SF, Tong GM, et al. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int. 2013;33:267–72.CrossRefPubMedPubMedCentral
11.
go back to reference Song Y, Wu J, Yan H, Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant. 2012;27:1639–44.CrossRefPubMed Song Y, Wu J, Yan H, Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant. 2012;27:1639–44.CrossRefPubMed
12.
go back to reference Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37:141–54.CrossRefPubMed Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37:141–54.CrossRefPubMed
13.
go back to reference Renaud CJ, Subramanian S, Tambyah PA, Lee EJ. The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton). 2011;16:174–9.CrossRefPubMed Renaud CJ, Subramanian S, Tambyah PA, Lee EJ. The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton). 2011;16:174–9.CrossRefPubMed
14.
go back to reference Lamb GS, Starke JR. Mycobacterium abscessus infections in children: a review of current literature. J Pediatric Infect Dis Soc. 2018;7:e131–44.CrossRefPubMed Lamb GS, Starke JR. Mycobacterium abscessus infections in children: a review of current literature. J Pediatric Infect Dis Soc. 2018;7:e131–44.CrossRefPubMed
15.
go back to reference Bertino JS Jr, Booker LA, Franck PA, Jenkins PL, Franck KR, Nafziger AN. Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring. J Infect Dis. 1993;167:173–9.CrossRefPubMed Bertino JS Jr, Booker LA, Franck PA, Jenkins PL, Franck KR, Nafziger AN. Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring. J Infect Dis. 1993;167:173–9.CrossRefPubMed
Metadata
Title
Peritoneal dialysis-associated infection caused by Mycobacterium abscessus in a pediatric patient on continuous peritoneal dialysis without switching to hemodialysis
Authors
Koji Takata
Takashi Omae
Yuri Hamano
Tomoaki Ishikawa
Keiji Nogami
Publication date
06-04-2024
Publisher
Springer Nature Singapore
Published in
CEN Case Reports
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-024-00875-1
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.